Highly glycosylated α1-acid glycoprotein is synthesized in myelocytes, stored in secondary granules, and released by activated neutrophils
- 7 June 2005
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 78 (2) , 462-470
- https://doi.org/10.1189/jlb.0105042
Abstract
α-1-Acid glycoprotein (AGP) is an acute-phase protein produced by hepatocytes and secreted into plasma in response to infection/injury. We recently assessed the transcriptional program of terminal granulocytic differentiation by microarray analysis of bone marrow (BM) populations highly enriched in promyelocytes, myelocytes/metamyelocytes (MYs), and BM neutrophils. These analyses demonstrated a transient, high mRNA expression of genuine secondary/tertiary granule proteins and AGP in MYs. In agreement with this, immunocytochemistry revealed the presence of AGP protein and the secondary granule protein lactoferrin in cells from the MY stage and throughout granulocytic differentiation. Immunoelectron microscopy demonstrated the colocalization of AGP and lactoferrin in secondary granules of neutrophils. This finding was substantiated by the failure to detect AGP and lactoferrin in blood cells from a patient with secondary/tertiary (specific) granule deficiency. In addition, Western blot analysis of subcellular fractions isolated from neutrophils revealed that neutrophil-derived AGP, localized in secondary granules, was abundant and highly glycosylated compared with endocytosed, plasma-derived AGP localized in secretory vesicles. Exocytosis studies further demonstrated a marked release of AGP and lactoferrin by activated neutrophils. Finally, induction of CCAAT/enhancer-binding protein (C/EBP)-ɛ in a myeloid cell line was shown to increase AGP transcript levels, indicating that AGP expression in myeloid cells, like in hepatocytes, is partially regulated by members of the C/EBP family. Overall, these findings define AGP as a genuine secondary granule protein of neutrophils. Hence, neutrophils, which constitute the first line of defense, are likely to serve as the primary local source of AGP at sites of infection or injury.Keywords
Funding Information
- Novo Nordisk Foundation
- Amalie Jørgensens Memorial Foundation
- Danish Cancer Research Foundation
- Danish Medical Research Council
- Gangsted Foundation
- Lundbeck Foundation
This publication has 44 references indexed in Scilit:
- Gene expression in human neutrophils during activation and priming by bacterial lipopolysaccharideJournal of Cellular Biochemistry, 2003
- A preliminary evaluation of the functional significance of alpha‐1‐acid glycoprotein glycosylation on wound healingBiomedical Chromatography, 2002
- High level of ?1-acid glycoprotein in human seminal plasma is associated with high branching and expression of Lewisa groups on its glycans: Supporting evidence for a prostatic originThe Prostate, 2002
- Neutrophil specific granule deficiency and mutations in the gene encoding transcription factor C/EBPϵCurrent Opinion in Hematology, 2002
- The Role of C/EBPε in the Terminal Stages of Granulocyte DifferentiationThe International Journal of Cell Cloning, 2001
- Alpha-1-acid glycoproteinPublished by Elsevier ,2000
- The Glucocorticoid Receptor Regulates the Binding of C/EPBβ on the Alpha-1-Acid Glycoprotein PromoterIn VivoDNA and Cell Biology, 1997
- Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells.The Journal of Experimental Medicine, 1993
- α1-Acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 β, interleukin-6 and tumor necrosis factor-α by human monocytes and alveolar and peritoneal macrophagesEuropean Journal of Immunology, 1992
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970